<?xml version="1.0" encoding="utf-8"?>
<?xml-stylesheet type="text/xsl" href="http://medicalxpress.com/tmpl/default/css/default/feedRSS.xsl"?>
<rss version="2.0" 
	xmlns:media="http://search.yahoo.com/mrss/">
<channel>
<title>Medical Xpress: PHYSorg news tagged with: percutaneous coronary intervention</title>
<link>http://medicalxpress.com/</link>
<language>en-us</language> 
<description>Medical Xpress internet news portal provides the latest news on Health and Medicine.</description>

 <item>
     <title>Clot-busting drug as effective as angioplasty</title>
   	 <description>A clot-busting therapy may benefit some heart attack patients who cannot have immediate angioplasty, according to research presented today at the American College of Cardiology's 62nd Annual Scientific Session.</description>
     <link>http://medicalxpress.com/news/2013-03-clot-busting-drug-effective-angioplasty.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 12 Mar 2013 10:38:45 EST</pubDate>
	 <guid isPermaLink="false">news282303438</guid>
	 
</item>
<item>
     <title>Lack of aspirin before angioplasty linked with higher mortality</title>
   	 <description>Despite recommendations from leading medical groups, a surprising number of patients are not given aspirin before artery-clearing coronary angioplasty and stenting, and those patients have a significantly higher in-hospital death rate, according to research from a Michigan network being presented at the American College of Cardiology's 62nd Annual Scientific Session.</description>
     <link>http://medicalxpress.com/news/2013-03-lack-aspirin-angioplasty-linked-higher.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 07 Mar 2013 14:40:01 EST</pubDate>
	 <guid isPermaLink="false">news281884099</guid>
	 
</item>
<item>
     <title>Gender influences ischemic time, outcomes after STEMI</title>
   	 <description>(HealthDay)—After ST-segment elevation myocardial infarction (STEMI) and primary percutaneous coronary intervention (PCI), women have longer ischemic times and are at a higher risk than men of early all-cause and cardiac mortality, according to research published in the Feb. 1 issue of The American Journal of Cardiology.</description>
     <link>http://medicalxpress.com/news/2013-02-gender-ischemic-outcomes-stemi.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 18 Feb 2013 10:10:06 EST</pubDate>
	 <guid isPermaLink="false">news280404031</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2013/genderinflue.jpg" width="90" height="90" />
</item>
<item>
     <title>Chest pain prior to a heart attack can protect the heart</title>
   	 <description>Patients who experience chest pain in the 24 hours preceding a heart attack, also called preinfarction angina, have smaller heart attacks and improved cardiac function in the contemporary cardiac stenting era, researchers found in a study published Jan. 22 in Circulation: Cardiovascular Interventions.</description>
     <link>http://medicalxpress.com/news/2013-02-chest-pain-prior-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 05 Feb 2013 09:36:55 EST</pubDate>
	 <guid isPermaLink="false">news279279409</guid>
	 
</item>
<item>
     <title>Administration of clopidogrel prior to PCI associated with reduction in major cardiac events</title>
   	 <description>Among patients scheduled for a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), pretreatment with the antiplatelet agent clopidogrel was not associated with a lower risk of overall mortality but was associated with a significantly lower risk of major coronary events, according to a review and meta-analysis of previous studies published in the December 19 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-12-administration-clopidogrel-prior-pci-reduction.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 18 Dec 2012 16:00:07 EST</pubDate>
	 <guid isPermaLink="false">news275068185</guid>
	 
</item>
<item>
     <title>Low responsiveness to clopidogrel predicts stent thrombosis, heart attack: But is not directly linked to death</title>
   	 <description>Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are more likely to have blood clots form on the stent and suffer a possible heart attack; conversely, patients with higher levels of platelet inhibition are at greater risk for bleeding complications. One-year results of the ADAPT-DES study were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.</description>
     <link>http://medicalxpress.com/news/2012-10-responsiveness-clopidogrel-stent-thrombosis-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Thu, 25 Oct 2012 15:19:09 EST</pubDate>
	 <guid isPermaLink="false">news270397123</guid>
	 
</item>
<item>
     <title>Mesh-covered stent helps restoration of blood flow in heart attack patients undergoing PCI</title>
   	 <description>A clinical trial found that the use of a next generation, micronet, mesh-covered stent demonstrated improved restoration of blood flow to heart tissue, compared to the use of either bare-metal or drug-eluting stents in heart attack patients undergoing angioplasty. Results of the MASTER trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium and will appear in the November 6th issue of the Journal of the American College of Cardiology. Sponsored by the Cardiovascular Research Foundation, TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.</description>
     <link>http://medicalxpress.com/news/2012-10-mesh-covered-stent-blood-heart-patients.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 24 Oct 2012 14:30:06 EST</pubDate>
	 <guid isPermaLink="false">news270305812</guid>
	 
</item>
<item>
     <title>FFR-guided PCI shows cost-effectiveness when compared to medical therapy for stable CAD</title>
   	 <description>A strategy of up-front percutaneous coronary intervention (PCI) for lesions confirmed to be obstructive by fractional flow reserve (FFR) was shown to be cost-effective in terms of quality-adjusted life years when compared to medical therapy alone. Results of the Cost-Effectiveness sub study of the FAME 2 trial were presented today at the 24th annual Transcatheter Cardiovascular Therapeutics (TCT) scientific symposium. Sponsored by the Cardiovascular Research Foundation (CRF), TCT is the world's premier educational meeting specializing in interventional cardiovascular medicine.</description>
     <link>http://medicalxpress.com/news/2012-10-ffr-guided-pci-cost-effectiveness-medical-therapy.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 24 Oct 2012 14:10:03 EST</pubDate>
	 <guid isPermaLink="false">news270304574</guid>
	 
</item>
<item>
     <title>Researchers ID potential patient population who may benefit from novel anti-platelet treatment</title>
   	 <description>Prasugrel, a novel anti-platelet therapy, is used to prevent recurrent cardiovascular events in patients who have had a prior heart attack, suffer severe chest pain and have been treated with coronary artery procedures (revascularization).</description>
     <link>http://medicalxpress.com/news/2012-10-id-potential-patient-population-benefit.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 24 Oct 2012 13:44:45 EST</pubDate>
	 <guid isPermaLink="false">news270305070</guid>
	 
</item>
<item>
     <title>Improving the safety of angioplasty in patients with coronary bypass graft disease</title>
   	 <description>Researchers at Thomas Jefferson University Hospital have shown that combining distal protection devices with the prophylactic use of the drug nicardipine is more effective at preventing life-threatening complications following a percutaneous coronary intervention (PCI) (angioplasty, stenting) on patients who have undergone previous bypass surgery than distal protection devices alone.</description>
     <link>http://medicalxpress.com/news/2012-10-safety-angioplasty-patients-coronary-bypass.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 22 Oct 2012 09:09:31 EST</pubDate>
	 <guid isPermaLink="false">news270115762</guid>
	 
</item>
<item>
     <title>Calling an ambulance improves heart attack survival</title>
   	 <description>The Acute Cardiac Care Congress 2012 is the first annual meeting of the newly launched Acute Cardiovascular Care Association (ACCA) of the European Society of Cardiology (ESC). It takes place from 20 to 22 October in Istanbul, Turkey, at the Istanbul Lufti Kirdar Convention and Exhibition Centre (ICEC).</description>
     <link>http://medicalxpress.com/news/2012-10-ambulance-heart-survival.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 20 Oct 2012 04:45:09 EST</pubDate>
	 <guid isPermaLink="false">news269927096</guid>
	 
</item>
<item>
     <title>Rates of procedures such as angioplasty lower in states with public reporting of outcomes</title>
   	 <description>In an analysis that included nearly 100,000 Medicare patients who had experienced a heart attack, the use of a percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) was lower for patients treated in states with public reporting of PCI outcomes compared with patients treated in states without public reporting, with these differences being particularly large in the highest-risk patients, according to a study in the October 10 issue of JAMA. However, the researchers found that there was no difference in overall heart attack survival rates between states with and without public reporting.</description>
     <link>http://medicalxpress.com/news/2012-10-procedures-angioplasty-states-outcomes.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 09 Oct 2012 16:25:07 EST</pubDate>
	 <guid isPermaLink="false">news269018695</guid>
	 
</item>
<item>
     <title>Decrease in early mortality in STEMI attributed to changing patient profile and behavior</title>
   	 <description>Data from four French nationwide registries of STEMI (ST-elevation myocardial infarction) patients initiated five years apart and covering more than 15 years show that mortality rate decreased by 68% over this period, from 13.7% to 4.4%. Around one quarter of this mortality reduction could be attributed to a change in patient characteristics.</description>
     <link>http://medicalxpress.com/news/2012-08-decrease-early-mortality-stemi-attributed.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 27 Aug 2012 12:00:57 EST</pubDate>
	 <guid isPermaLink="false">news265287649</guid>
	 
</item>
<item>
     <title>Study examines factors associated with improvement in survival from heart attack in France</title>
   	 <description>The overall rate of death in patients hospitalized with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack) decreased from 1995 to 2010 in France, with possible factors associated with this decline including an increase in the proportion of STEMI patients who were women younger than age 60, and an increase in the use of reperfusion therapy and recommended therapeutic measures following a heart attack, according to a study being published online by JAMA. The study is being released early to coincide with its presentation at the European Society of Cardiology Congress.</description>
     <link>http://medicalxpress.com/news/2012-08-factors-survival-heart-france.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 27 Aug 2012 02:00:01 EST</pubDate>
	 <guid isPermaLink="false">news265186863</guid>
	 
</item>
<item>
     <title>Use of newer-generation drug-releasing stent results in lower rate of adverse cardiac events</title>
   	 <description>Compared with a bare-metal stent, the use of a stent with a biodegradable polymer that releases the drug biolimus resulted in a lower rate of major adverse cardiac events at 1 year among patients with ST-segment elevation myocardial infarction (STEMI; a certain pattern on an electrocardiogram following a heart attack) undergoing primary percutaneous coronary intervention (PCI; procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries), according to a study in the August 22/29 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2012-08-newer-generation-drug-releasing-stent-results-adverse.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 21 Aug 2012 16:00:01 EST</pubDate>
	 <guid isPermaLink="false">news264782719</guid>
	 
</item>
<item>
     <title>ECGs administered by paramedics can speed treatment for severe heart attacks</title>
   	 <description>A new program that trains emergency medical service technicians (EMS) to read electrocardiograms so that they can evaluate patients with chest pain, and expedite treatment for the severe heart condition known as ST-segment elevation myocardial infarction (STEMI), a serious form of heart attack, has excellent results and should become the standard of care, according to two studies published in the current issue of the Canadian Journal of Cardiology.</description>
     <link>http://medicalxpress.com/news/2012-07-ecgs-paramedics-treatment-severe-heart.html</link>
	 <category>Cardiology</category>
	 <pubDate>Fri, 20 Jul 2012 10:03:44 EST</pubDate>
	 <guid isPermaLink="false">news261997366</guid>
	 
</item>
<item>
     <title>Life-saving primary PCI rising in Stent for Life countries</title>
   	 <description>Life saving primary percutaneous coronary intervention (PPCI) treatment is increasing in countries participating in the Stent for Life Initiative.</description>
     <link>http://medicalxpress.com/news/2012-05-life-saving-primary-pci-stent-life.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 16 May 2012 12:27:53 EST</pubDate>
	 <guid isPermaLink="false">news256390065</guid>
	 
</item>
<item>
     <title>Study examines exercise testing in asymptomatic patients after coronary revascularization</title>
   	 <description>Asymptomatic patients who undergo treadmill exercise echocardiography (ExE) after coronary revascularization may be identified as being at high risk but those patients do not appear to have more favorable outcomes with repeated revascularization, according to a report published Online First by Archives of Internal Medicine, a JAMA Network publication. The article is part of the journal's Less is More series.</description>
     <link>http://medicalxpress.com/news/2012-05-asymptomatic-patients-coronary-revascularization.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 14 May 2012 11:00:02 EST</pubDate>
	 <guid isPermaLink="false">news256208973</guid>
	 
</item>
<item>
     <title>Good long-term outcomes for drug-eluting stents</title>
   	 <description>(HealthDay) -- Meta-analysis of randomized clinical trials (RCTs) suggests that drug-eluting stents (DESs) significantly reduce repeat revascularizations, with no increase in stent thrombosis (ST), mortality, or recurrent myocardial infarction, but data from observational studies indicate an increased risk of ST with DES use, according to research published in the April 1 issue of The American Journal of Cardiology.</description>
     <link>http://medicalxpress.com/news/2012-04-good-long-term-outcomes-drug-eluting-stents.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 04 Apr 2012 12:46:11 EST</pubDate>
	 <guid isPermaLink="false">news252762346</guid>
	 <media:thumbnail url="http://s.ph-cdn.com/newman/gfx/news/tmb/2012/goodlongterm.jpg" width="90" height="90" />
</item>
<item>
     <title>Infusion of drug into the coronary artery may help reduce size of heart damage after heart attack</title>
   	 <description>Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a percutaneous coronary intervention and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle at 30 days, while a procedure that involved use of a catheter to remove the blood clot blocking that coronary artery did not produce these results, according to a study appearing in JAMA. The study is being published early online to coincide with its presentation at the American College of Cardiology's annual scientific sessions.</description>
     <link>http://medicalxpress.com/news/2012-03-infusion-drug-coronary-artery-size.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sun, 25 Mar 2012 16:30:01 EST</pubDate>
	 <guid isPermaLink="false">news251904424</guid>
	 
</item>
<item>
     <title>Significant mismatch between PCI capable-hospitals and need</title>
   	 <description>There is an imbalance between the rapid growth of cardiac catheterization laboratories, which provide percutaneous coronary intervention (PCI) procedures, relative to the growth in the overall U.S. population, as well as patients who experience an acute heart attack, or ST-elevation myocardial infarction (STEMI), according to a study presented March 25 at the 61st annual American College of Cardiology (ACC) scientific session.</description>
     <link>http://medicalxpress.com/news/2012-03-significant-mismatch-pci-capable-hospitals.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sun, 25 Mar 2012 14:21:15 EST</pubDate>
	 <guid isPermaLink="false">news251904052</guid>
	 
</item>
<item>
     <title>Complications in patients undergoing percutaneous coronary intervention tend to occur within first 30 days</title>
   	 <description>Percutaneous coronary intervention (PCI), also known as coronary angioplasty or angioplasty, is a procedure used to treat acute coronary syndromes. PCI involves opening a blocked blood vessel by threading and inflating a balloon-tipped tube into the vessel. Sometimes a stent is also inserted to keep the blood vessel open.</description>
     <link>http://medicalxpress.com/news/2012-03-complications-patients-percutaneous-coronary-intervention.html</link>
	 <category>Cardiology</category>
	 <pubDate>Sat, 24 Mar 2012 19:01:40 EST</pubDate>
	 <guid isPermaLink="false">news251834480</guid>
	 
</item>
<item>
     <title>Hospitals invest heavily in new heart attack care programs but fail to improve access</title>
   	 <description>In a new study, researchers have found a 44 percent increase since 2001 in the number of hospitals that offer definitive emergency care to patients with heart attack, but only a 1 percent increase in access to that care. The study, led by Thomas W. Concannon, PhD, Assistant Professor Tufts Medical Center and Tufts University School of Medicine, will be published January 1, 2012 in Circulation: Cardiovascular Quality and Outcomes, a journal of the American Heart Association.</description>
     <link>http://medicalxpress.com/news/2011-12-hospitals-invest-heavily-heart-access.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 19 Dec 2011 12:31:28 EST</pubDate>
	 <guid isPermaLink="false">news243520275</guid>
	 
</item>
<item>
     <title>Severity of heart attack is dependent on the time of day</title>
   	 <description>The size of a heart attack and subsequent left-ventricular function are significantly different based on the time of day onset of ischemia, according to a first of its kind study in humans, published online Nov. 17 in Circulation Research. The greatest amount of injury to the heart occurs when individuals have a heart attack between 1:00am and 5:00am.</description>
     <link>http://medicalxpress.com/news/2011-11-severity-heart-day.html</link>
	 <category>Cardiology</category>
	 <pubDate>Mon, 21 Nov 2011 10:19:50 EST</pubDate>
	 <guid isPermaLink="false">news241093141</guid>
	 
</item>
<item>
     <title>Canadian Journal of Cardiology publishes report on delayed vs. immediate coronary stenting</title>
   	 <description>The Canadian Journal of Cardiology has published a paper on the timing of coronary stenting, a thought-provoking paper that challenges one of the dogmas of acute heart attack management today.</description>
     <link>http://medicalxpress.com/news/2011-10-canadian-journal-cardiology-publishes-coronary.html</link>
	 <category>Cardiology</category>
	 <pubDate>Wed, 19 Oct 2011 09:36:43 EST</pubDate>
	 <guid isPermaLink="false">news238235797</guid>
	 
</item>
<item>
     <title>Study shows balloon pump use prior to angioplasty does not reduce heart muscle damage</title>
   	 <description>Inserting intra-aortic balloon pumps prior to angioplasty in patients with acute myocardial infarction (AMI) does not reduce the scope of heart muscle damage, a condition referred to as infarct size, according to a new study conducted by Duke University Medical Center researchers.</description>
     <link>http://medicalxpress.com/news/2011-08-balloon-prior-angioplasty-heart-muscle.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 30 Aug 2011 03:31:37 EST</pubDate>
	 <guid isPermaLink="false">news233893878</guid>
	 
</item>
<item>
     <title>Most heart-attack patients needing procedure at another hospital not transferred in recommended time</title>
   	 <description>Only about 10 percent of patients with a certain type of heart attack who need to be transferred to another hospital for a PCI (procedures such as balloon angioplasty or stent placement used to open narrowed coronary arteries) are transferred within the recommended time of 30 minutes, according to a study in the June 22/29 issue of JAMA.</description>
     <link>http://medicalxpress.com/news/2011-06-heart-attack-patients-procedure-hospital.html</link>
	 <category>Cardiology</category>
	 <pubDate>Tue, 21 Jun 2011 16:33:22 EST</pubDate>
	 <guid isPermaLink="false">news227892792</guid>
	 
</item>


</channel>
</rss>
